期刊文献+

氨甲环酸片联合谷胱甘与胶原贴对黄褐斑患者的临床研究 被引量:27

Clinical trial of tranexamic acid tablets combined with glutathione and coltagen in patients with chloasma
原文传递
导出
摘要 目的观察氨甲环酸片联合谷胱甘肽注射液、胶原贴对黄褐斑患者近期疗效及黄褐斑面积和严重程度指数(MASI)评分的影响。方法 110例黄褐斑患者随机分为对照组和试验组,每组55例。对照组患者用谷胱甘肽治疗联合胶原贴外敷,静脉滴注谷胱甘肽注射液1.2 g,加入0.9%NaCl或5%葡萄糖注射液250 mL中,正常滴速;胶原贴敷料外敷30 min,每周治疗2次,8周为1个疗程。试验组在对照组的基础上口服氨甲环酸片,每次250 mg,每日2次,连服2个月。比较2组患者的近期疗效及MASI评分情况。结果试验组总有效率为87.27%(48/55例),对照组为69.09%(38/55例),差异有统计学意义(P<0.05)。治疗2,4,6个月后,对照组患者的MASI评分分别为(10.42±3.39),(7.94±2.36),(6.97±1.30)分;试验组分别为(9.17±2.86),(6.38±2.87),(5.14±1.30)分,差异有统计学意义(P<0.05)。试验组出现1例恶心,未经特殊处理后自行好转;对照组未出现明显的药物不良反应。结论氨甲环酸联合谷胱甘肽、胶原贴可以明显改善黄褐斑患者的皮损面积和严重程度,疗效显著。 Objective To evaluate the clinical efficacy and melisma area severity index(MASI) score of tranexamic acid combined with glutathione,coltagen effect in patients with chloasma.Methods A total of110 patients with chloasma were randomly divided into control group and treatment group,each group 55 cases.Control group was treated with glutathione combined with collagen patch applying,glutathione injection1.2 g add 0.9%NaCl or 5%glucose injection 250 mL,intravenous drip,drip speed normal;collagen dressing with 30 min treatment,2times a week,8 weeks a courses.Treatment group was treated with oral ammonia tranexamic acid tablets 250 mg based on control group,2 times a day,and last for 2 months.Compared the clincial efficacy and MASI score between the two groups.Results The total efficacy in treatment group was 87.27%(48/55),had significant difference with that in control group,which was 69.09%(38/55,P〈0.05).After 2,4,6months,MASI scores in control group were 10.42 ±3.39,7.94 ±2.36,6.97 ± 1.30,had significant difference with those in treatment group,which were 9.17 ± 2.86,6.38 ± 2.87,5.14 ± 1.30(P〈0.05).Patients in treatment group had 1 case of nausea,without special treatment,and no adverse drug reactions occurred in control group.Conclusion Tranexamic acid combined with glutathione,collagen paste can obviously improve the chloasma patients with psoriasis area and severity,the curative effect is remarkable.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第6期558-560,共3页 The Chinese Journal of Clinical Pharmacology
基金 重庆市卫生和计生委中医药科技基金资助项目(zy20150230)
关键词 氨甲环酸 谷胱甘肽 胶原贴 黄褐斑 tranexamic acid glutathione collagen chloasma
  • 相关文献

参考文献13

二级参考文献130

  • 1黄褐斑的临床诊断和疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:312
  • 2Njoo MD,Das PK,Bos JD,et al.Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris.Arch Dermatol,1999,135(4):407-413.
  • 3Hamzavi I,Jain H,McLean D,et al.Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool:the Vitiligo Area Scoring Index.Arch Dermatol,2004,140(6):677-683.
  • 4杨庆琪,赵广.黄褐斑的治疗进展[J].中国医学文摘(皮肤科学),2007,24(4):213-216. 被引量:8
  • 5Pichardo R, Vallejos Q, Feldman SR, et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol, 2009, 48( 1 ): 22-26.
  • 6Freitag FM, Cestari TF, Leopoldo LR, et al. Effect of melasma on quality of life in a sample of women living in southern Brazil. J Eur Acad Dermatol Venereol, 2008, 22(6): 655-662.
  • 7Lakhdar H, Zouhair K, Khadir K, et al. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol, 2007, 21 (6): 738-742.
  • 8Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol, 2011, 65(4): 689-698.
  • 9Moncada B, Sahagon-Sonchez LK, Torres-Alvarez B, et al. Molecular structure and concentration of melanin in the stratum corneum of patients with melasma. Photodermatol Photoimmunol Photomed, 2009, 25(3): 159-160.
  • 10Jo HY, Kim CK, Suh IB, et ah Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma. J Dermatol, 2009, 36(1 ): 10-16.

共引文献671

同被引文献187

引证文献27

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部